As the primary cause of cancer-related deaths in females, chemoresistance in breast cancer is often associated with the abnormal expression of PFKFB3, such as in tamoxifen (TAM) resistance (Zhao et al. 2024). This evidence concerns the gene PFKFB3 and breast cancer.